Lucid Diagnostics (NASDAQ:LUCD) stock slips as the company announces an AdCom meeting scheduled to discuss Medicare coverage ...

FDA approved Lyme kit - ID FISH Technology, Inc. Using both IgM and IgG tests allows for full diagnostic coverage of a disease. IgM antibodies are produced first and suggest a current or recent ...

The status symbols CMOs are into More than 15,000 marketing leaders and creatives descended on the French Riviera for this year's Cannes Lions International Festival of Creativity in France.

Mexico’s green, white and red flag has become a defining symbol of the protests in Los Angeles.

Fact check: Assessing Medicaid coverage losses under House reconciliation bill The majority of coverage losses under the bill would come from those who became eligible for Medicaid due to an ...

The MRI shows a brain tumor in an inauspicious location, and a brain biopsy will entail high risks for a patient who had consulted doctors due to double vision. Situations such as this case ...

AI technologies are transforming medical diagnostic methods by advancing precision medicine and enabling early detection through data-driven decision-making. By the year 2025 AI technologies became ...

Caris Life Sciences announced plans to go public, testing a technology initial public offering market that’s been frozen over for most of the year. The Irving-based AI diagnostic company said on ...

The US Food and Drug Administration (FDA) has granted 510 (k) clearance to the first blood test to aid in diagnosing Alzheimer’s disease (AD).

Snap-on says its new Pro-Link+ combines hardware and software for a complete code-based diagnostic and repair platform for all makes of trucks.

Panelists discuss how managed care organizations can improve Alzheimer diagnostic test access while navigating complex coverage challenges for amyloid-targeting therapies across traditional ...

Fintel reports that on April 28, 2025, D. Boral Capital initiated coverage of Co-Diagnostics (NasdaqCM:CODX) with a Buy recommendation. Analyst Price Forecast Suggests 191.51% Upside As of April ...